Search research articles
Contact Us
Filters
Showing results (1-10 of 223) with videos related to
Page
of 23
Sort By:
European Urology
|
March 4, 2011
Improving the outcome for invasive bladder cancer: the debate regarding pelvic lymphadenectomy moves from if to how
James W F Catto
Journal of Molecular Medicine (Berlin, Germany)
|
October 6, 2006
The changing face of prostate cancer: can gains in epigenetic knowledge translate into improvements in clinical care?
James W F Catto
European Urology Focus
|
June 25, 2019
Is Social Media Worth the Risk for Health Care Professionals?
James W F Catto
European Urology
|
February 12, 2008
More nomograms or better evidence of efficacy: what do we need in urologic oncology?
James W F Catto
European Urology
|
August 4, 2009
Words of wisdom. Re: Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
James W F Catto
European Urology
|
May 6, 2011
Thirty-five years of intravesical bacillus Calmette-Guérin for bladder cancer: where now?
James W F Catto
European Urology
|
April 20, 2011
Health care spending, social policy, public health, and life expectancy: what cancer outcomes can tell us beyond treatment efficacy
James W F Catto
BJU International
|
July 19, 2017
Speeding up recovery from radical cystectomy: how low can we go?
James W F Catto
European Urology
|
September 27, 2022
Monkeypox and the Urologist: Playing an Important Role in This Emerging Global Outbreak
James W F Catto
European Urology Focus
|
December 7, 2025
Exciting Times in Urological Oncology: Rapid Advances and Greater Complexity Are Changing Practice and Improving Outcomes
Shilpa Gupta, James W F Catto
Page
of 23
Search research articles
Search
Showing results (1-10 of 223) with videos related to
Sort By:
Page
of 23
European Urology
|
March 4, 2011
Improving the outcome for invasive bladder cancer: the debate regarding pelvic lymphadenectomy moves from if to how
James W F Catto
Journal of Molecular Medicine (Berlin, Germany)
|
October 6, 2006
The changing face of prostate cancer: can gains in epigenetic knowledge translate into improvements in clinical care?
James W F Catto
European Urology Focus
|
June 25, 2019
Is Social Media Worth the Risk for Health Care Professionals?
James W F Catto
European Urology
|
February 12, 2008
More nomograms or better evidence of efficacy: what do we need in urologic oncology?
James W F Catto
European Urology
|
August 4, 2009
Words of wisdom. Re: Sequence variant on 8q24 confers susceptibility to urinary bladder cancer
James W F Catto
European Urology
|
May 6, 2011
Thirty-five years of intravesical bacillus Calmette-Guérin for bladder cancer: where now?
James W F Catto
European Urology
|
April 20, 2011
Health care spending, social policy, public health, and life expectancy: what cancer outcomes can tell us beyond treatment efficacy
James W F Catto
BJU International
|
July 19, 2017
Speeding up recovery from radical cystectomy: how low can we go?
James W F Catto
European Urology
|
September 27, 2022
Monkeypox and the Urologist: Playing an Important Role in This Emerging Global Outbreak
James W F Catto
European Urology Focus
|
December 7, 2025
Exciting Times in Urological Oncology: Rapid Advances and Greater Complexity Are Changing Practice and Improving Outcomes
Shilpa Gupta, James W F Catto
Page
of 23